Professor Maurice Iwu |
As the world continued to battle
with efforts aimed at finding cure to HIV/AIDS, the US Food and Drug
Administration (FDA) has announced another breakthrough in the treatment of the
disease with the discovery of an oral botanical drug, Crofelemer.
The new drug is the second
botanical, and an orally administered drug to be approved by FDA since 2006.
The latest breakthrough owes its
success to a pioneering research carried out in the United States by a team of
scientists including Nigeria's Professor Maurice Iwu, an acclaimed
pharmacologist and tropical medicine expert.
The first botanical drug to be
approved in the United States was a topical green tea extract, Veregen, in
2006. Both botanical drugs meet all US pharmaceutical requirements and can be
dispensed only by prescription.
However, ''Crofelemer is the first
drug to be approved in the United States to treat HIV -associated diarrhea. It
is derived from the latex of the South American sangre de drago tree (dragon's
blood, Croton lechleri). A red, blood-resembling latex leaks from the tree when
its bark is cut, and it is this substance that contains the novel polymolecular
structure crofelemer, originally developed and standardized by Shaman
Pharmaceuticals. Fulyzag is the second botanical drug approved by the agency.
The drug's approval marks an important event in the decades-long history of
crofelemer.''
The latest ''Healthnews,'' in a
report entitled, ''Nigeria's Maurice Iwu, others record breakthrough in
HIV/AIDS treatment: Amazon tree-derived medicine cleared for usage in HIV
patients with diarrhea,'' stated, ''On New Year's Eve of 2012, the US Food and
Drug Administration announced its approval of crofelemer, marking the second
time a botanical, and the first time an orally administered botanical, has
received drug approval from the Administration. The first botanical drug to be
approved in the United States was a topical green tea extract, Veregen in 2006.
Both botanical drugs meet all US pharmaceutical requirements and can be dispensed
only by prescription.
''The latest breakthrough owes its
success to a pioneering research carried out in the United States by a team of
scientists which included Nigeria's Professor Maurice Iwu, an acclaimed
pharmacologist and tropical medicine expert.
I am very happy for you
Professor Iwu. Congrats.
No comments:
Post a Comment